STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells
- PMID: 30158673
- DOI: 10.1038/s41388-018-0449-z
STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells
Abstract
Immunosuppressive myeloid-derived suppressor cells (MDSC) subvert antitumor immunity and limit the efficacy of chimeric antigen receptor T cells (CAR-T). Previously, we reported that the GM-CSF/JAK2/STAT3 axis drives liver-associated MDSC (L-MDSC) proliferation and blockade of this axis rescued antitumor immunity. We extended these findings in our murine liver metastasis (LM) model, by treating tumor-bearing mice with STAT3 inhibitors (STATTIC or BBI608) to further our understanding of how STAT3 drives L-MDSC suppressive function. STAT3 inhibition caused significant reduction of tumor burden as well as L-MDSC frequencies due to decrease in pSTAT3 levels. L-MDSC isolated from STATTIC or BBI608-treated mice had significantly reduced suppressive function. STAT3 inhibition of L-MDSC was associated with enhanced antitumor activity of CAR-T. Further investigation demonstrated activation of apoptotic signaling pathways in L-MDSC following STAT3 inhibition as evidenced by an upregulation of the pro-apoptotic proteins Bax, cleaved caspase-3, and downregulation of the anti-apoptotic protein Bcl-2. Accordingly, there was also a decrease of pro-survival markers, pErk and pAkt, and an increase in pro-death marker, Fas, with activation of downstream JNK and p38 MAPK. These findings represent a previously unrecognized link between STAT3 inhibition and Fas-induced apoptosis of MDSCs. Our findings suggest that inhibiting STAT3 has potential clinical application for enhancing the efficacy of CAR-T cells in LM through modulation of L-MDSC.
Similar articles
-
Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.Cancer Gene Ther. 2016 Jun;23(6):188-98. doi: 10.1038/cgt.2016.19. Epub 2016 May 20. Cancer Gene Ther. 2016. PMID: 27199222
-
Intratumoral injection of mRNA encoding survivin in combination with STAT3 inhibitor stattic enhances antitumor effects.Cancer Lett. 2024 Aug 28;598:217111. doi: 10.1016/j.canlet.2024.217111. Epub 2024 Jul 6. Cancer Lett. 2024. PMID: 38972347
-
Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T.Cancer Immunol Immunother. 2015 Jul;64(7):817-29. doi: 10.1007/s00262-015-1692-6. Epub 2015 Apr 8. Cancer Immunol Immunother. 2015. PMID: 25850344 Free PMC article.
-
Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer.Arch Pharm Res. 2016 Nov;39(11):1597-1608. doi: 10.1007/s12272-016-0822-9. Epub 2016 Aug 29. Arch Pharm Res. 2016. PMID: 27572156 Review.
-
Myeloid cells as a _target for oligonucleotide therapeutics: turning obstacles into opportunities.Cancer Immunol Immunother. 2017 Aug;66(8):979-988. doi: 10.1007/s00262-017-1966-2. Epub 2017 Feb 18. Cancer Immunol Immunother. 2017. PMID: 28214929 Free PMC article. Review.
Cited by
-
P-STAT3 Inhibition Activates Endoplasmic Reticulum Stress-Induced Splenocyte Apoptosis in Chronic Stress.Front Physiol. 2020 Jun 30;11:680. doi: 10.3389/fphys.2020.00680. eCollection 2020. Front Physiol. 2020. PMID: 32714202 Free PMC article.
-
Immunosuppressive cells in cancer: mechanisms and potential therapeutic _targets.J Hematol Oncol. 2022 May 18;15(1):61. doi: 10.1186/s13045-022-01282-8. J Hematol Oncol. 2022. PMID: 35585567 Free PMC article. Review.
-
Carbon ion radiotherapy boosts anti-tumour immune responses by inhibiting myeloid-derived suppressor cells in melanoma-bearing mice.Cell Death Discov. 2021 Nov 3;7(1):332. doi: 10.1038/s41420-021-00731-6. Cell Death Discov. 2021. PMID: 34732697 Free PMC article.
-
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.J Hematol Oncol. 2024 May 8;17(1):31. doi: 10.1186/s13045-024-01544-7. J Hematol Oncol. 2024. PMID: 38720342 Free PMC article. Review.
-
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic _targets in cancer.Signal Transduct _target Ther. 2021 Oct 7;6(1):362. doi: 10.1038/s41392-021-00670-9. Signal Transduct _target Ther. 2021. PMID: 34620838 Free PMC article. Review.
References
-
- Guha P, Reha J, Katz SC. Immunosuppression in liver tumors: opening the portal to effective immunotherapy. Cancer Gene Ther. 2017;24:114–20. - DOI
-
- Katz SC, Pillarisetty VG, Bleier JI, Kingham TP, Chaudhry UI, Shah AB, et al. Conventional liver CD4 T cells are functionally distinct and suppressed by environmental factors. Hepatology. 2005;42:293–300. - DOI
-
- Katz SC, Bamboat ZM, Maker AV, Shia J, Pillarisetty VG, Yopp AC, et al. Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases. Ann Surg Oncol. 2013;20:946–55. - DOI
-
- Katz SC, Pillarisetty V, Bamboat ZM, Shia J, Hedvat C, Gonen M, et al. T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases. Ann Surg Oncol. 2009;16:2524–30. - DOI
-
- Turcotte S, Katz SC, Shia J, Jarnagin WR, Kingham TP, Allen PJ, et al. Tumor MHC class I expression improves the prognostic value of T-cell density in resected colorectal liver metastases. Cancer Immunol Res. 2014;2:530–7. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous